Physician profile
Helen Keunsun Chin Yang
NPI 1376770743
$1,030.85
in general payments reported to CMS, 2019-2025
14 companies · $251 in 2025
The $251 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.07 · 2020: $63.75 · 2021: $124 · 2022: $127 · 2023: $268 · 2024: $135 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $414.09 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Glaxosmithkline, LLC. | $122.75 | 2020-2024 | Bexsero |
| Pfizer INC. | $95.77 | 2019-2024 | |
| Cranial Technologies, INC | $77.25 | 2022-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $63.83 | 2021-2023 | |
| Kaleo, INC. | $52.49 | 2021 | |
| Neos Therapeutics, Lp | $39.32 | 2019-2020 | |
| Genzyme Corporation | $32.82 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $31.46 | 2025 | Zoryve |
| Ucb, INC. | $25.46 | 2022 | |
| Acadia Pharmaceuticals INC | $24.56 | 2023 | Daybue |
| Verrica Pharmaceuticals INC. | $22.39 | 2025 | Ycanth |
| Alk-Abello, INC | $14.42 | 2025 | Neffy |
| Seqirus USA INC | $14.24 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.